Oxidation of polyamines and brain injury

Neurochemical Research

Volumn 25, Issue 4, 2000, Pages 471-490

  Seiler, N ^a  

^a INSERM   (France)

Author keywords

Amine oxidases; Brain damage; Polyamine oxidase; Polyamines

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINOALDEHYDE; HYDROGEN PEROXIDE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN METABOLISM; ENZYME KINETICS; ENZYME MECHANISM; METABOLIC REGULATION; OXIDATION; PRIORITY JOURNAL;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BRAIN; BRAIN INJURIES; CATTLE; ENZYME INHIBITORS; HUMANS; MICE; NEURONS; OXIDATION-REDUCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PUTRESCINE; RATS; SPERMIDINE; SPERMINE;

EID: 0034126310     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007508008731     Document Type: Article

References (171)

1. nd ed. Plenum Press, New York.
2. Romano, C. and Williams, K. 1994. Modulation of NMDA receptors by polyamines. Pages 81-106, in Carter, C. (ed.) The Neuropharmacology of Polyamines, Academic Press, London.
3. Williams, K. 1997. Modulation and block of ion channels: A new biology of polyamines. Cellular Signalling 13:1-13.
4. + channels. Science 266:1068-1072.
5. Lopatin, A. N., Makhina, E. N., and Nichols, C. G. 1995. The mechanism of inward rectification of potassium channels: "Long-pore plugging" by cytoplasmic polyamines. J. Gen. Physiol. 106:923-955.
6. Nichols, C. G. and Lopatin, A. N. 1997. Inward rectifier potassium channels. Annu. Rev. Physiol. 59:171-191.
7. Johnson, T. D. 1998. Polyamines in cerebral ischemia. Volume 50, pages 193-258, in Jucker E. (ed.) Progress in Drug Research. Birkhäuser, Basel.
8. Paschen, W. 1994. Polyamines in cerebral ischemia. Pages 223-254, in Carter, C. (ed.), The Neuropharmacology of Polyamines, Academic Press, London.
9. Gilad, G. M. and Gilad, V. H. 1992. Polyamines in neurotrauma. Ubiquitous molecules in search of a function. Biochem. Pharmacol. 44:401-407.
10. Cohen, S. S. 1998. A Guide to the Polyamines. 595 pages, Oxford University Press, New York, Oxford.
11. Pajunen, A. E. Hietala, O. A., Virransalo, E. L., and Piha, R. S. 1978. Ornithine decarboxylase and adenosylmethionine decarboxylase in mouse brain. Effect of electrical stimulation. J. Neurochem. 30:281-293.
12. Bondy, S., Mitchell, C., Rahman, S., and Mason, G. 1987. Regional variation in response of cerebral ornithine decarboxylase to electroconvulsive shock. Neurochem. Pathol. 7:129-141.
13. Hayashi, Y., Hattori, Y., Moriwaki, A., Saeki, K., and Hori, Y. 1989. Changes in polyamine concentrations in amygdaloid-kindled rats. J. Neurochem. 53: 986-988.
14. Arai, A., Baudry, M., Stäubli, U., Lynch, G., and Gall, C. 1990. Induction of ornithine decarboxylase by subseizure stimulation in the hippocampus in vivo. Mol. Brain Res. 7:167-169.
15. Pajunen, A. E., Hietala, O. A., Baruch-Virransalo, E. L., and Piha, R. S. 1979. The effect of DL-allylglycine on polyamine and GABA metabolism in mouse brain. J. Neurochem. 32: 1401-1408.
16. Gardiner, I. M. and de Belleroche, J. 1990. Reversal of neurotoxin-induced ornithine decarboxylase activity in rat cerebral cortex by nimodipine. A potential neuroprotective mechanism. Stroke 21 (Suppl. 12):93-94.
17. De Vera, N., Artigas, F., Serratosa, J., and Martinez, E. 1991. Changes in polyamine levels in rat brain after systemic kainic acid administration: relationship to convulsant activity and brain damage. J. Neurochem. 57:1-8.
18. Martinez, E., de Vera, N., and Artigas, F. 1991. Differential response of rat brain polyamines to convulsant agents. Life Sci. 48:77-84.
19. Baudry, M. and Najm, I. 1994. Kainate-induced seizure activity stimulates the polyamine interconversion pathway in rat brain. Neurosci. Lett. 171:151-154.
20. Hayashi, Y., Morizumi, Y., Hattori, Y., and Tanaka, J. 1999. Pentylenetetrazol-induced kindling stimulates the polyamine interconversion pathway in rat brain. Brain Res. 828: 184-188.
21. Koenig, H., Goldstone, A. D., and Lu, C. Y. 1983; Blood-brain barrier breakdown in brain edema following cold injury is mediated by microvascular polyamines. Biochim. Biophys. Res. Commun. 116:1039-1045.
22. Desiderio, M. A., Zini, I., Davalli, P., Zoli, M., Corti, A., Fuxe, K., and Agnati, L. F. 1988. Polyamines, ornithine decarboxylase, and diamine oxidase in substantia nigra and striatum of the male rat after hemitransection. J. Neurochem. 51:25-31.
23. Walsh, T. J., Emerich, D. F., and Bondy, S. C. 1989. Destruction of specific hippocampal cell fields increases ornithine decarboxylase activity: modulation of the biochemical but not the histological changes by ganglioside GM1. Exp. Neurol. 105: 54-61.
24. Baskaya, M. F. K., Rao, A. M., Prasad, M. R., and Dempsey, R. J. 1996. Regional activity of ornithine decarboxylase and edema formation after traumatic brain injury. Neurosurgery 38:140-145.
25. Gilad, M., Gilad, V. H., Wyatt, R. J., and Casero, R. A. Jr. 1992. Chronic lithium treatment prevents the dexamethasone-induced increase of brain polyamine metabolizing enzymes. Life Sci. 50:PL149-PL154.
26. Koenig, H., Goldstone, A. D., Lu, C. Y., and Trout, J. J. 1990. Brain polyamines are controlled by N-methyl-D-aspartate receptors during ischemia and recirculation. Stroke 21 (Suppl. III):98-102.
27. Porcella, A., Page, D., Voltz, C., Carter, C., Scatton, B., and Bartholini, G. 1991. Difluoromethylornithine protects against the neurotoxic effects of intrastriatally administered N-metyl-D-aspartate in vivo. Eur. J. Pharmacol. 199:267-269.
28. Kish, S. J., Wilson, J. M., and Fletcher, P. J. 1991. The polyamine synthesis inhibitor α-difluoromethylornithine is neuro-protective against N-methyl-D-aspartate-induced brain damage in vivo. Eur. J. Pharmacol. 209:101-103.
29. Reed, L. J. and de Belleroche, J. 1992. Induction of ornithine decarboxylase in cerebral cortex by excitotoxin lesions of nucleus basalis: Association with postsynaptic responsiveness and N-methyl-D-aspartate receptor activation. J. Neurochem. 55: 780-787.
30. Facchinetti, F., Virgili, M. Mignani, P., Barnabei, O., and Contestabile, A. 1992. Induction of brain ornithine decarboxylase after systemic or intrastriatal administration of kainic acid. Neurosci. Lett. 140:59-62.
31. Wood, H. and de Belleroche, J. 1993. Induction of ornithine decarboxylase mRNA in cerebral cortex in response to kainate lesion of nucleus basalis: involvement of NMDA receptors. Neurosci. Lett. 111:176-182.
32. Fike, J. R., Gobbel, G. T., Marton, L. J., and Seilhan, T. M. 1994. Radiation brain injury is reduced by the polyamine inhibitor α-difluoromethylornithine. Radiat. Res. 138:99-106.
33. Dienel, G. A., Cruz, N. F., and Rosenfeld, S. J. 1985. Temporal profiles of proteins responsive to transient ischemia. J. Neurochem. 44:600-610.
34. Paschen, W., Hallmayer, J., Mies, G. and Rohn, G. 1990. Ornithine decarboxylase activity and putrescine levels in reversible cerebral ischemia of Mongolian gerbils: effect of barbiturate. J. Cereb. Blood Flow Metab. 10:236-242.
35. Paschen, W., Csiba, L., Röhn, G., and Bereczki, D. (1991) Polyamine metabolism in transient focal ischemia of rat brain. Brain Res. 566:354-357.
36. Dempsey, R. J., Combs, D. J., Olson, J. W., and Maley, M. 1988. Brain ornithine decarboxylase activity following transient cerebral ischaemia: relationship to cerebral edema development. Neurol. Res. 10:175-178.
37. Gilad, G. M., Gilad, V. H., and Wyatt, R. J. 1993. Accumulation of exogenous polyamines in gerbil brain after ischemia. Mol. Chem. Neuropathol. 18:197-210.
38. Zoli, M., Zini, L, Gimaldi, R., Biagini, G., and Agnati, L. F. 1993. Effects of polyamine synthesis blockade on neuronal loss and astroglial reaction after transient forebrain ischemia. Int. J. Devl. Neurosci. 11:175-187.
39. Rao, A. M., Baskaya, M. K., Maley, M. E., Prasad, M. R., and Dempsey, R. J. 1995. Ornithine decarboxylase activity and edema formation in cerebral ischemia of conscious gerbils. J. Neurochem. 65:2639-2643.
40. Dogan, A., Rao, A. M., Hatcher, J., Rao, V. L. R., Baskaya, M. K., and Dempsey, R. J. 1999. Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. J. Neurochem. 72:765-770.
41. Gilad, G. M., Gilad, V. H., and Rabey, J. M. 1996. Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia. Neurosci. Lett. 216: 33-36.
42. Holt, A. and Baker, G. B. 1995. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Pages 187-197, in Hu, P. M., Tipton, K. F. and Boulton, A. A. (eds.) Current Neurochemical Aspects of Biogenic Amines, (Progress in Brain Research Volume 106), Elsevier, Amsterdam.
43. Gilad, G. M., Salame, K., Rabey, J. M., and Gilad, V. H. 1995. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. 58:PL41-PL46.
44. Bernstein, H. G. and Müller, M. 1999. The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems. Prog. Neurobiol. 57:485-505.
45. Bernstein, H. G., Grecksch, G., Rütherich, H., Müller, M., Becker, A. and Pajunen, A. E. I. 1995. Long-lasting expression of ornithine decarboxylase immunoreactivity in rat brain astrocytes after pentylenetetrazol-induced chemical kindling. Neurosci. Res. Commun. 16:83-88.
46. Bey, P., Danzin, C., and Jung, M. J. 1987. Inhibition of basic amino acid decarboxylases involved in polyamine biosynthesis. Pages 1-31, in McCann, P. P., Pegg, A. E. and Sjoerdsma, A. (eds.), Inhibition of Polyamine Metabolism, Academic Press, Orlando.
47. Porcella, A., Carter, C., Page, D., Voltz, C., Lloyd, K. G., Serrano, A., and Scatton, B. 1991. The effects of N-methyl-D-aspartate and kainate lesions of the rat striatum on striatal ornithine decarboxylase activity and polyamine levels. Brain Res. 549: 205-212.
48. Schmitz, M. P., Combs, D. J. and Dempsey, R. J. 1993. Difluoromethylornithine decreases postischemic brain edema and blood-brain barrier breakdown. Neurosurgery 33: 882-888.
49. Paschen, W., Rõhn, G., Meese, C. O., Djuricic, B., and Schmidt-Kastner. R. 1988. Polyamine metabolism in reversible cerebral ischemia: effect of α-difluoromethylornithine. Brain Res. 453: 9-16.
50. Kindy, M. S., Hu, Y. and Dempsey, R. J. 1994. Blockade of ornithine decarboxylase enzyme protects against ischemic brain damage. J. Cereb. Blood Flow Metab. 14:1040-1045.
51. Paschen, W., Hallmayer, J., Mies, G., and Rõhn, G. 1988. Relationship between putrescine content and density of ischemic cell damage in the brain of Mongolian gerbils: effect of nimodipine and barbiturate. Acta Neuropathol. (Berlin) 76:388-394.
52. Seiler, N., Bolkenius, F. N., and Rennert, O. M. 1981. Interconversion, catabolism and elimination of the polyamines. Med. Biol. 59:334-346.
53. Hölttä, E. 1977. Oxidation of spermidine and spermine in rat liver: Purification and properties of polyamine oxidase. Biochemistry 16:306-311.
54. Morgan, D. M. L. 1998. Amine oxidases; Pages 48-63, in Bardocz, S., White, A., and Hajos G. (eds.) Biogenically Active Amines in Food, Volume II: Metabolic Effects of Biologically Active Amines in Food (COST 917), European Communities, Luxembourg.
55. Seiler, N. 1990. Polyamine metabolism. Digestion 46 (Suppl. 2):319-330.
56. Seiler, N. 1994. Formation, catabolism and properties of the natural polyamines. Pages 1-36, in Carter, C. (ed.) The Neuropharmacology of Polyamines, Academic Press, London.
57. Seiler, N. 1995. Polyamine oxidase, properties and functions. Pages 333-344, in Yu, P. M., Tipton, K. F., and Boulton, A. A. (eds.) Current Neurochemical and Pharmacological Aspects of Biogenic Amines (Progress in Brain Reserch Volume 106) Elsevier, Amsterdam.
58. Pegg, A. E. 1988. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:759-774.
59. Bachrach, U. and Heimer, Y. M. (eds.). 1989. The Physiology of Polyamines, 2 Volumes, CRC Press, Boca Raton,
60. Morgan, D. M. L. 1999. Polyamines. An overview. Mol. Biotechnol. 11:229-250.
61. Parchment, R. E. 1996. An overview of the known and suspected mechanisms for control of apoptosis by polyamines and their metabolites. Pages 99-150 in Nishioka, K. (ed.) Polyamines in Cancer: Basic Mechanisms and Clinical Approaches, Springer/ Landes, New York, Austin.
62. Ivanova, S., Botchkina, G. I., Al-Abed, Y., Meistrell III., M., Batliwalla, F., Dubinsky, J. M., Iadecola, C., Wang, H., Gregerssen, P. K., Eaton, J. W., and Tracey, K. J. 1998. Cerebral ischemia enhances polyamine oxidation: Identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J. Exp. Med. 188:327-340.
63. Shin, W. W., Fong, W. F., Pang, S. F., and Wong, P. C. L. 1985. Limited blood-brain barrier transport of polyamines. J. Neurochem. 44:1056-1059.
64. Fischer, H. A., Korr, H., Seiler, N. and Werner, G. 1972. Interrelationships between polyamines and nucleic acids. III. Metabolic and autoradiographic studies of putrescine in mouse brain. Brain Res. 39:197-212.
65. Anderson, T. R. and Schanberg, S. M. 1972. Ornithine decarboxylase activity in developing rat brain. J. Neurochem. 19: 1471-1481.
66. Seiler, N. and Lamberty, U. 1975. Interrelations between polyamines and nucleic acids: changes of polyamine and nucleic acid concentrations in the developing rat brain. J. Neurochem. 24:4-13.
67. Seiler, N. and Lamberty, U. 1975 Polyamines and nucleic acids in brains and hearts of newborn and adult autophagous and heterophagous vertebrates. Comp. Biochem. Physiol. 52B:419-425.
68. Schmidt, G. L. and Cantoni, G. L. 1973. Adenosylmethionine decarboxylase in developing rat brain. J. Neurochem. 20: 1373-1385.
69. Antrup, H. and Seiler, N. 1980. On the turnover of polyamines spermidine and spermine in mouse brain and other organs. Neurochem. Res. 5:123143.
70. Seiler, N. and Bolkenius, F. N. 1985. Polyamine reutilization and turnover in brain. Neurochem. Res. 10:529-544.
71. Seiler, N., Bolkenius, F. N., Bey, P., Mamont, P. S., and Danzin, C. 1985. Biochemical significance of inhibition of polyamine oxidase. Pages 305-319, in Selmeci, L., Brosnan, M. E. and Seiler, N. (eds.) Recent Progress in Polyamine Research. Akadémiai Kiado, Budapest.
72. Bolkenius, F. N. and Seiler, N. 1986. Developmental aspects of polyamine interconversion in rat brain. Int. J. Devl. Neurosci. 4:217-224.
73. Hayashi, Y. and Baudry, M. 1995. Effect of kainate-induced seizure activity on the polyamine interconversion pathway in juvenile rat brain. Devl. Brain Res. 87:96-99.
74. Persson, L., Svensson, F., and Loevkvist-Wallstroem, E. 1996. Regulation of polyamine metabolism. Pages 19-43, in Nishioka, K. (ed.) Polyamines in Cancer: Basic Mechanisms and Clinical Approaches. Springer/Landes, New York, Austin.
75. Persson, L., Wallström, E. L., Nasizadeh, S., Dartsch, C., Jeppson, A., Wendt, A., and Holmgren, J. 1998. Regulation of mammalian ornithine decarboxylase. Biochem. Soc. Trans. 26:575-579.
76. Shantz, L. M. and Pegg, A. E. 1999. Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. Int. J. Biochem. Cell Biol. 31:107-122.
77. Pegg, A. E., Xiong, H., Feith, D. J., and Shantz, L. M. 1998. S-Adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem. Soc. Trans. 26:580-586.
78. 1-acetyltransferase by intracellular polyamine pools. Evidence for a functional role in polyamine homeostasis. FEBS Lett. 321:179-183.
79. 1-acetyltransferase - the turning point in polyamine metabolism. FASEB J. 7:653-661.
80. Kilpelainen, P. T. and Hietala, O. A. 1994. Activation of rat brain ornithine decarboxylase by GTP. Biochem. J. 300:577-582.
81. Hayashi, S. and Murakami, Y. 1995. Rapid and regulated degradation of ornithine decarboxylase. Biochem. J. 306:1-10.
82. Hayashi, S., Murakami, Y. and Matsufuji, S. 1996. Ornithine decarboxylase antizyme: a novel type of regulatory protein. TIBS 21:27-30.
83. Mitchell, J. L. A., Judd, G. G., Bareyal-Leyser, A., and Ling, S. Y. 1994. Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue culture cells. Biochem. J. 299:19-22.
84. Seiler, N. and Dezeure, F. 1990. Polyamine transport in mammalian cells. Int. J. Biochem. 22:211-218.
85. Seiler, N., Delcros, J. G. and Moulinoux, J. P. 1996. Polyamine transport in mammalian cells. An update. Int. J. Biochem. Cell Biol. 28:843-861.
86. Seiler, N., Bink, G. and Grove, J. 1979. Regulatory interrelationships between GABA and polyamines. I. Brain GABA levels and polyamine metabolism. Neurochem. Res. 4:425-435.
87. Daune, G. and Seiler, N. 1988. Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain. Neurochem. Res. 13:69-75.
88. Seiler, N., Daune, G., Bolkenius, F. N. and Knödgen, B. 1989. Ornithine aminotransferase activity, tissue ornithine concentration and polyamine metabolism. Int. J. Biochem. 21:425-432.
89. Pegg, A. E., Poulin, R., and Coward, J. K. (1995). Use of amino-propyltransferase inhibitors and non-metabolizable analogs to study polyamine regulation and function. Int. J. Biochem. Cell Biol. 27:425-442.
90. Mitchell, J. L. A., Mahan, D. W., McCann, P., and Qasba, P. 1985. Dicyclohexylamine effects on HTC cell polyamine content and ornithine decarboxylase activity. Biochim. Biophys. Acta 840:309-316.
91. Seiler, N., Bolkenius, F. N., Knödgen, B., and Mamont, P. S. 1980. Polyamine oxidase in rat tissues. Biochim. Biophys. Acta 615:480-488.
92. Suzuki, O., Matsumoto, T., and Katsumata, Y. 1984. Determination of polyamine oxidase activities in human tissues. Experientia 40:838-839.
93. Raina, A., Pajula, R. L., and Eloranta, T. 1976. A rapid assay method for spermidine and spermine synthases: Distribution of polyamine synthesizing enzymes and methionine adenosyltransferase in rat tissues. FEBS Lett. 67:252-255.
94. Hayashi, H., Yoshida, H., Hashimoto, F., and Okazeri, S. 1989. Changes in polyamine-oxidizing capacity of peroxisomes under various physiological conditions in rats. Biochim. Biophys. Acta 991:310-316.
95. Bolkenius, F. N. and Seiler, N. 1981. Acetylderivatives as intermediates in polyamine catabolism. Int. J. Biochem. 13: 287-292.
96. Blankenship, J. and Walle, T. 1978. In vitro studies of enzymatic synthesis and metabolism of N-acetylated polyamines. Pages 97-110, in Campbell, R. A., Morris, D. R., Bartos, D., Daves, G. D., and Bartos, F. (eds.) Advances in Polyamine Research, Volume 2, Raven Press, New York.
97. Bolkenius, F. N. and Seiler, N. 1989. New substrates of polyamine oxidase. Biol. Chem. Hoppe-Seyler, 370:525-531.
98. Bitonti, A. J., Dumont, J. A., Bush, T. L., Stemerick, D. M., Edwards, M. L., and McCann, P. P. 1990. Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase. J. Biol. Chem. 265:382-388.
99. Seiler, N. 1987. Inhibition of enzymes oxidizing polyamines. Pages 49-77, in McCann, P. P., Pegg, A. E., and Sjoerdsma, A. (eds.) Inhibition of Polyamine Metabolism. Academic Press, Orlando.
100. Schuler, W. 1952. Zur Hemmung der Diaminoxydase. Experientia 7:230-232.
101. Libby, P. R. and Porter, C. W. 1992. Inhibition of enzymes of polyamine-back conversion by pentamidine and berenil. Biochem. Phrmacol. 44:830-832
102. Williams-Ashman, H. G. and Seidenfeld, J. 1986. Aspects of the biochemical pharmacology of methylglyoxal-bis(guanylhydrazone). Biochem. Pharmacol. 35:1217-1225.
103. Hölttä, E., Hannonen, P., Pispa, J., and Jänne, J. 1973. Effect of methylglyoxal bis(guanylhydrazone) on polyamine metabolism in normal and regenerating rat liver and rat thymus. Biochem. J. 136:669-676.
104. Regenass, U., Mett, H., Stanek, Mueller, M., Kramer, D., and Porter, C. W. 1994. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res. 54:3210-3217.
105. Seiler, N., Delcros, J. G., Cipolla, B., Chamaillard, L., Havouis, R., Quemener, V. and Moulinoux, J. P. 1996. Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma. Drug. Res. 46(1) 311-315.
106. Bey, P., Bolkenius, F. N., Seiler, N., and Casara, P. 1985. N-2,3-Butadienyl-1,4-butanediamine derivatives: Potent irreversible inactivators of mammalian polyamine oxidase. J. Med. Chem. 28:1-2.
107. Bolkenius, F. N. and Seiler, N. 1989. Polyamine oxidase inhibitors. Pages 245-256, in Sandler, M. and Smith, H. J. (eds.) Design of Enzyme Inhibitors as Drugs, Oxford University Press, Oxford.
108. Zeller, E. A. 1963. Monoamine and polyamine analogues; Pages 53-58, in Hoechster, R. M. and Quastel, J. H. (eds.) Metabolic Inhibitors, Volume 2, Academic Press, New York.
109. Seiler, N. 1992. Polyamine catabolism and elimination by the vertebrate organism. Pages 65-85, in Dowling, R. H., Fölsch, U. R. and Löser, C. (eds.) Polyamines in the Gastrointestinal Tract. Kluwer Academic Publishers, Dordrecht.
110. Seiler, N., Bolkenius, F. N., and Knödgen, B. 1985. The influence of catabolic reactions on polyamine excretion. Biochem. J. 225:219-226.
111. Alarcon, R. A. 1970. Acrolein. IV. Evidence for the formation of the cytotoxic aldehyde from enzymatically oxidized spermine or spermidine. Arch. Biochem. Biophys. 137:365-372.
112. Kimes, B. W. and Morris, D. R. 1971. Preparation and stability of oxidised polyamines. Biochim. Biophys. Acta 228: 223-234.
113. Israel, M., Zoll, E. C. Muhammad, N., and Modest, E. J. 1973. Synthesis and antitumor evaluation of the presumed cytotoxic metabolites of spermine and N,N'-bis(3-aminopropyl)nonane-1,9-diamine. J. Med. Chem. 16:1-5.
114. Morgan, D. M. L. 1988. Polyamine oxidases and oxidized polyamines. Pages 203-229, in Bachrach, U. and Heimer, Y. M. (eds.) The Physiology of Polyamines, Volume 1. CRC Press, Boca Raton.
115. Wolverkamp, M. C. J. and De Bruin, R. W. F. 1994. Diamine oxidase: An overview of historical, biochemical and functional aspects. Dig. Dis. 12:2-14.
116. Burkard, W. P., Gey, K. F., and Pletscher, A. 1963. Diamine oxidase in the brain of vertebrates. J. Neurochem. 10:183-186.
117. Seiler, N. and Al Therib, M. J. 1974. Putrescine catabolism in mammalian brain. Biochem. J. 144:29-35.
118. Seiler, N., Schmidt-Glenewinkel, T., and Sarhan, S. 1979. On the formation of γ-aminobutyric acid from putrescine in brain. J. Biochem. (Tokyo) 86:277-278.
119. Dowling, R. H. 1990. Polyamines in intestinal adaptation and disease. Digestion 46 (Suppl. 2):331-344.
120. Desiderio, A. M., Sessa A., and Perin, A. 1982. Induction of diamine oxidase activity in rat kidney during compensatory hypertrophy. Biochim. Biophys. Acta 714:243-249.
121. Perin, A., Sessa, A., and Desiderio, M. A. 1983. Induction of diamine oxidase activity in some processes of growth. Pages 175-181, in Bachrach, U., Kaye, A., and Chayen, R. (eds.) Advances in Polyamine Research, Volume 4; Raven Press, New York.
122. Perin, A. Sessa, A. and Desiderio, M. A. 1985. Diamine oxidase in regenerating and hypertrophic tissues. Pages 179-194, in Mondovi, B. (ed.) Structure and Functions of amine oxidases; CRC Press, Boca Raton.
123. Perin, A., Sessa, A. and Desiderio, M. A. 1986. Response of tissue diamine oxidase activity to polyamine administration. Biochem. J. 234:119-123.
124. Hirsch, J. G. 1953. Spermine oxidase: an amine oxidase with specificity for spermine and spermidine. J. Exp. Med. 97: 345-355.
125. Janes, S. M. and Klinman, J. M. 1991. An investigation of bovine serum amine oxidase active site stoichiometry: evidence for an aminotransferase mechanism involving two carbonyl co-factors per enzyme dimer. Biochemistry 30:4599-4605.
126. Gahl, W. A. and Pilot, H. C. 1982. Polyamine degradation in foetal and adult bovine serum. Biochem. J. 202:603-611.
127. Tabor, C. W., Tabor, H., and Bachrach, U. 1964. Identification of the aminoaldehydes produced by oxidation of spermine and spermidine with purified plasma amine oxidase. J. Biol. Chem. 239:2194-22203.
128. Bardsley, W. G. Inhibitors of copper amine oxidases. Pages 135-152, in Mondovi, B. (ed.) Structure and Functions of Amine Oxidases, CRC Press, Boca Raton.
129. Wolff, D. J. and Lubeskie, A. 1995. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch. Biochem. Biophys. 316: 290-301.
130. Seiler, N., Knõdgen, B., Gittos, W., Chan, W. Y., Griesmann, G., and Rennert, O. M. 1981. On the formation of amino acids deriving from spermidine and spermine. Biochem. J. 200: 123-132.
131. Gaugas, J. M. 1981. Potent inhibition of diamine oxidase with the hydroxybenzyloxyamines NSD-1039, NSD 1531 and NSD 1024. Biochem. Pharmacol. 30:3121-3122.
132. Gahl, W. A., Vale, A. M. and Pitot, H. C. 1982. Spermidine oxidase in human pregnancy serum. Biochem. J. 201:161-166.
133. Morgan, D. M. L. 1985. Human pregnancy-serum associated polyamine oxidase: partial purification and properties. Biochem. Soc. Trans. 13:351.
134. Gahl, W. A. and Pitot, H. C. 1981. Acetylated polyamines as substrates for human pregnancy serum diamine oxidase. Life Sci. 29:2177-2179.
135. Brunton, V. G., Grant, M. H, and Wallace, H. M. 1991. Mechanism of spermine toxicity in baby hamster kidney (BHK) cells. Biochem. J. 280:193-198.
136. He, Y., Kashiwagi, K., Fukuchi, J., Terao, K., Shirahata, A. and Igarashi, K. 1993. Correlation between the inhibition of cell growth by accumulation of polyamines and the decrease of magnesium and ATP. Eur. J. Biochem. 217:89-96.
137. Poulin, R., Pelletier, G., and Pegg, A. E. 1995. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem. J. 311: 723-727.
138. Stefanelli, C., Bonavita, F., Stanic, I., Mignani, M., Facchini, A., Pignatti, C., Flamigni, F., and Caldarera, C. M. 1998. Spermine causes caspase activation in leukaemia cells. FEBS Lett. 437:233-236.
139. Alhonen, L., Halmekytö, M., Kosma, V. M., Wahlfors, J., Kauppinen, R. and Jänne, J. 1995. Life-long over-expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration. Int. J. Cancer 63:402-404.
140. Lukkarainen, J., Kauppinen, R. A., Koistinaho, J. Halmekytö, M, Alhonen, L., and Jänne, J. 1995. Cerebral energy metabolism and immediate early gene induction following severe incomplete ischaemia in transgenic mice overexpressing the human ornithine decarboxylase gene: evidence that putrescine is not neurotoxic in vivo. Eur. J. Neurosci. 7:1840-1849.
141. Smith, C. J., Maschler, R., Maurer, H. R. and Allen, J. C. 1983. Inhibition of cells in culture by polyamines does not depend on the presence of ruminant serum. Cell Tissue Kinet. 16: 269-276.
142. Gilad, G. M. and Gilad, V. H. 1987. Neurotoxicity of polyamines in rat cerebellar cultures. Prog. Clin. Biol. Res. 253:193-206.
143. Fahey, J. M., Pritchard, G. A., and Miller, L. G. 1993. Polyamine neurotoxicity is antagonized by dizocilpine in cultured chick cortical neurons. Neurosci. Lett. 161:109-112.
144. Sparapani, M., Dall'Ollio, R., Gandolfi, O., Ciani, E., and Contestabile, A. 1997. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Exp. Neurol. 148:157-166.
145. Virgili, M., Sparapani, M., Facchinetti, F., Ciani, E., Dall'Olio, R., and Contestabile, A. 1992. In vitro and in vivo evidence for spermine and spermidine neurotoxicity. Neurodegeneration 1:273-279.
146. Henle, K. J. Moss, A. J., and Nagle, W. A. 1986. Mechanism of spermidine cytotoxicity at 37°C and 43°C in Chinese hamster ovary cells. Can. Res. 46:175-182.
147. Averill-Bates, D. A., Agostinelli, E., Przybytkowski, E., and Mondovi, B. 1994. Aldehyde dehydrogenase and cytotoxicity of purified bovine serum amine oxidase and spermine in Chinese hamster ovary cells. Biochem. Cell Biol. 72:36-42
148. Smith, C. J., Hussain, J. I., and Allen, J. C. 1985. Inhibition of cell proliferation by polyamines does not depend on the cytotoxicity of acrolein. Biochem. Soc. Trans. 13:326-329.
149. Thornberry, N. A., Rosen, A., and Nicholson, D. 1997. Control of apoptosis by proteases. Adv. Pharmacol. 41:155-177.
150. Markwell, M. A., Berger, S. P., and Paul, S. M. 1990. The polyamine synthesis inhibitor α-difluoromethylornithine blocks NMDA-induced neurotoxicity. Eur. J. Pharmacol. 182:607-609.
151. Seiler, N., Sarhan, S., and Roth-Schechter, B. F. 1984. Polyamines and the development of isolated neurons in cell culture. Neurochem. Res. 9:871-886.
152. Seiler, N. 1991. Pharmacological properties of the natural polyamines and their depletion by biosynthesis inhibitors as a therapeutic approach. Pages 107-159, in Jucker, E. (ed.) Progress in Drug Research, Volume 37, Birkhäuser, Basel.
153. Glantz, L., Nates, J. L., Trembovler, V., Bass, R., and Shohami, E. 1996. Polyamines induce blood-brain barrier disruption and edema formation in the rat. J. Basic. Clin. Physiol. Pharmacol. 7:1-10.
154. Anderson, D. J., Crossland, J. and Shaw, G. G. 1975. The actions of spermidine and spermine on the central nervous system. Neuropharmacology 14:571-577.
155. Doyle, K. M. and Shaw, G. G. 1994. The mechanism of the neurotoxic effects of spermidine. Biochem. Soc. Trans. 22: 386S.
156. Doyle, K. M. and Shaw, G. G. 1996. Investigation of the involvement of the N-methyl-D-aspartate receptor macrocomplex in the development of spermine-induced CNS excitation in vivo. Br. J. Pharmacol. 117:1803-1808.
157. Doyle, K. M. and Shaw, G. G. 1998. Investigation of the actions and antagonist activity of some polyamine analogues in vivo. Br. J. Pharmacol. 124:386-390.
158. Bourdiol, F., Page, D., Serrano, A., Carter, C., Benavides, J., and Scatton, B. 1992. Neurotoxic effects of the intrastriatal injection of spermine and spermidine: lack of involvement of NMDA receptors. Brain Res. 596:183-188.
159. Otsuki, M., Davidson, M., Goodenough, S., Wilce, P. A., Tase, C., and Matsumoto, I. 1995. In vivo pharmacological study of spermine-induced neurotoxicity. Neurosci. Lett. 196:81-84.
160. Fage, D., Voltz, C., and Carter, C. 1992. Delayed and prolonged release of spermine and spermidine following the release of glutamate from "ischemic" hippocampal slices in vitro. Pages 97-103, in Kriegelstein, J. and Oberpichler-Schwenk, H. (eds.) Pharmacology of Cerebral Ischemia. Wissenschaftliche. Verlagsgesellschaft, Stuttgart.
161. Fage, D., Carboni, S., Voltz, C., Scatton, B., and Carter, C. 1993. Ornithine decarboxylase inhibition or NMDA receptor anatagonism reduce cortical polyamine efflux associated with dialysis probe implantation. Neurosci. Lett. 149:173-176.
162. Porcella, A., Page, D., Voltz, C., Bourdiol, P., Benavides, J., Scatton, B., and Carter, C. 1992. Implication of the polyamines in the neurotoxic effects of N-methyl-D-aspartate. Neurol. Res. 14 (Suppl. 2):181-183.
163. Carter, C., Poignet, H., Carboni, S., Page, D., Voltz, C., and Scatton, B. 1995. Release of spermidine from the rat cortex following permanent middle cerebral artery occlusion. Fundam. Clin. Pharmacol. 9:129-140.
164. Cockroft, K. M., Meistrell, M. III, Zimmerman, G. A., Risucci, D., Bloom, O., Cerami, A., and Tracey, K. J. 1996. Cerebro-protective effects of aminoguanidine in a rodent model of stroke. Stroke, 27:1393-1398.
165. Dogan, A., Rao, A. M., Baskaya, M. K., Hatcher, J., Temiz, C., Rao, V. L., and Dempsey, R. J. 1999. Contribution of polyamine oxidase to brain injury after trauma. J. Neurosurg. 90:1078-1082.
166. Zimmerman, G. A., Meistrell III, M., Bloom, O., Cockroft, K. M., Bianchi, M., Risucci, D., Broome, J., Farmer, A., Cerami, H., Vlassara, H., and Tracey, K. J. 1995. Neurotoxicity of advanced glycation endproducts during focal stroke, and neuroprotective effect of aminoguanidine. Proc. Nat. Acad. Sci. USA 92:3744-3748.
167. Sattler, J. and Lorenz, W. 1990. Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model. J. Neural Transm. Suppl. 32:291-314.
168. Flayeh, K. A. 1988. Spermidine oxidase activity in serum of normal and schizophrenic subjects. Clin. Chem. 34:401-403.
169. Quash, G. and Taylor, D. R. 1970. Serum β-aminopropionaldehyde: identification and origin. Clin. Chim. Acta 30:17-23.
170. Van den Berg, G. A., Elzinga, H., Nagel, G. T., Kingma, A. W., and Muskiet, F. A. J. 1984. Catabolism of the polyamines in the rat. Polyamines and their non-α-amino acid metabolites. Biochim. Biophys. Acta 802:175-187.
171. Bachrach, U. 1981. Oxidation of polyamines and diamines. Pages 151-168, in Morris, D. R. and Marton, L. J. (eds.) Polyamines in Biology and Medicine, Marcel Dekker, New York.